The global Phase Ib multicenter trial of CS5001 (ROR1 ADC) is being advanced rapidly and efficiently in Australia and China, with its R&D progress ranking among the top two globally. In combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results